International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: https://doi.org/10.5281/zenodo.14000018
Original Research Article
Comparative Analysis of MRI and CT Imaging in Diagnosing Liver Lesions in Adults
Published
Oct. 28, 2024
Abstract

Background: Liver lesions are often found incidentally, and accurate imaging is decisive for determining their nature and guiding treatment. This read aims to compare the characteristic truths of attractive ringing imagery (MRI) and calculated imaging (CT) in inch-big patients presenting with liver lesions, focusing on differentiating kinds from malevolent lesions.Methods: A prospective study was conducted on 120 adult patients (60 males and 60 females) with a mean age of 45 years (range: 25-75 years). Apiece diligent underwent both magnetic resonance imaging and cat imagery. The diagnostic precision sensitivity specificity positive foretelling value (PPV) and negative foretelling value (NPV) of both imaging modalities were calculated and compared.Results: MRI demonstrated a sensitivity of 92% (95% CI: 84%-97%). specificity of 88% (95% CI: 79%-93%), PPV of 90% (95% CI: 82%-95%), and NPV of 91% (95% CI: 83%-96%). Cat imagery showed amp sensibility of 85% (95% CI: 77%-92%). specificity of 80% (95% CI: 71%-88%), ppv of 86% (95% CI: 78%-92%), and npv of 79% (95% CI: 70%-87%). The overall diagnostic The precision of MRI was 90% compared to CT's 82%. Magnetic resonance imaging is incontestable, and importantly, higher sensibility (p0.05).Conclusion: MRI provides superior diagnostic accuracy and sensitivity for characterizing liver lesions in adults, making it a preferred imaging modality. However, CT remains a valuable tool for initial assessment due to its broader availability and faster imaging time.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
684 Views
496 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved